BG51250A3 - Метод за получаване на тиадиазоло-и оксадиазоло тетрахидроизохинолиново съединение - Google Patents

Метод за получаване на тиадиазоло-и оксадиазоло тетрахидроизохинолиново съединение Download PDF

Info

Publication number
BG51250A3
BG51250A3 BG048339A BG4833980A BG51250A3 BG 51250 A3 BG51250 A3 BG 51250A3 BG 048339 A BG048339 A BG 048339A BG 4833980 A BG4833980 A BG 4833980A BG 51250 A3 BG51250 A3 BG 51250A3
Authority
BG
Bulgaria
Prior art keywords
tetrahydroisoquinoline
acetyl
compound
hydrochloric acid
amino
Prior art date
Application number
BG048339A
Other languages
Bulgarian (bg)
English (en)
Inventor
William Bondinell
Gerald Girard
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG51250A3 publication Critical patent/BG51250A3/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
BG048339A 1979-07-02 1980-07-01 Метод за получаване на тиадиазоло-и оксадиазоло тетрахидроизохинолиново съединение BG51250A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5434379A 1979-07-02 1979-07-02

Publications (1)

Publication Number Publication Date
BG51250A3 true BG51250A3 (bg) 1993-03-15

Family

ID=21990408

Family Applications (1)

Application Number Title Priority Date Filing Date
BG048339A BG51250A3 (bg) 1979-07-02 1980-07-01 Метод за получаване на тиадиазоло-и оксадиазоло тетрахидроизохинолиново съединение

Country Status (30)

Country Link
EP (1) EP0023761B1 (cs)
JP (1) JPS5610192A (cs)
KR (1) KR840000396B1 (cs)
AR (1) AR225925A1 (cs)
AT (1) ATE6515T1 (cs)
AU (1) AU531641B2 (cs)
BG (1) BG51250A3 (cs)
CA (1) CA1129415A (cs)
CS (1) CS215064B2 (cs)
DD (1) DD151750A5 (cs)
DE (1) DE3066826D1 (cs)
DK (1) DK151029C (cs)
ES (1) ES492971A0 (cs)
FI (1) FI67221C (cs)
GR (1) GR69206B (cs)
HU (1) HU179382B (cs)
IE (1) IE50290B1 (cs)
IL (1) IL60426A (cs)
IN (1) IN160542B (cs)
MX (1) MX6317E (cs)
NO (1) NO801951L (cs)
NZ (1) NZ194156A (cs)
PH (1) PH17042A (cs)
PL (2) PL127098B1 (cs)
PT (1) PT71458A (cs)
RO (1) RO79707A (cs)
SU (1) SU1072809A3 (cs)
YU (1) YU171180A (cs)
ZA (1) ZA802987B (cs)
ZW (1) ZW14680A1 (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939164A (en) * 1974-02-08 1976-02-17 Smithkline Corporation 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds
US3988339A (en) * 1974-02-08 1976-10-26 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase

Also Published As

Publication number Publication date
ZA802987B (en) 1981-05-27
IL60426A (en) 1984-03-30
FI67221C (fi) 1985-02-11
PT71458A (en) 1980-07-01
HU179382B (en) 1982-10-28
KR830002791A (ko) 1983-05-30
FI67221B (fi) 1984-10-31
ES8105736A1 (es) 1981-06-01
CA1129415A (en) 1982-08-10
ZW14680A1 (en) 1980-09-24
IE50290B1 (en) 1986-03-19
PH17042A (en) 1984-05-17
EP0023761A1 (en) 1981-02-11
CS215064B2 (en) 1982-07-30
EP0023761B1 (en) 1984-03-07
IN160542B (cs) 1987-07-18
GR69206B (cs) 1982-05-07
JPS5610192A (en) 1981-02-02
MX6317E (es) 1985-04-01
NO801951L (no) 1981-01-05
ATE6515T1 (de) 1984-03-15
DD151750A5 (de) 1981-11-04
IE801352L (en) 1981-01-02
FI802112A7 (fi) 1981-01-03
AU5967780A (en) 1981-01-15
DE3066826D1 (en) 1984-04-12
RO79707A (ro) 1982-08-17
YU171180A (en) 1983-09-30
NZ194156A (en) 1983-03-15
DK274280A (da) 1981-01-03
SU1072809A3 (ru) 1984-02-07
IL60426A0 (en) 1980-09-16
ES492971A0 (es) 1981-06-01
AR225925A1 (es) 1982-05-14
PL127098B1 (en) 1983-09-30
DK151029B (da) 1987-10-12
AU531641B2 (en) 1983-09-01
KR840000396B1 (ko) 1984-03-30
DK151029C (da) 1988-03-07
PL230619A1 (cs) 1981-12-11
PL225377A1 (cs) 1981-08-21

Similar Documents

Publication Publication Date Title
US4340598A (en) Hypotensive imidazole derivatives
RU2136682C1 (ru) Имидазопиридины, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
NZ198047A (en) Tricyclic imidazole derivatives carrying a pyrid-2-ylmethylthio substituent
EP0173520B1 (en) Tricyclic oxindole antiinflammatory agents
US4128666A (en) 4 AND 5-Halo substituted 2-indanamine compounds
EP0172608A1 (en) Novel triazine derivative, process for preparing same and pharmaceutical preparations containing same
US4352809A (en) Method of producing alpha2 antagonism
US4192888A (en) Pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase
PL80112B1 (cs)
WO2001025237A1 (en) Novel imidazopyridine carbonitrile compounds
BG51250A3 (bg) Метод за получаване на тиадиазоло-и оксадиазоло тетрахидроизохинолиново съединение
US4309348A (en) Tricyclic indole derivatives
US4258049A (en) Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines
US4242346A (en) Bis-2N-alkylene tetrahydroisoquinoline compounds
FI91871B (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
US4272531A (en) 3,3'-Bis-methylene-1,3-benzo-thiazine compounds
US4322417A (en) Antihypertensive polyfluoroisopropyl tricyclic carbostyrils
EP0465191B1 (en) Bicyclic sulfur-containing compounds
RU2068415C1 (ru) 5,7-диокси-2-метил-8-/4-(3-окси-1-(1-пропил)пиперидинил/-4н-1-бензопиран-4-он или его стереоизомеры или фармакологически приемлемые кислотно-аддитивные соли и способ их получения
KR820000493B1 (ko) 퀴나졸린 유도체의 제조방법
KR820000492B1 (ko) 퀴나졸린 유도체의 제조방법
US4639457A (en) Benzocycloheptapyridone compounds for treating congestive heart failure
KR820000096B1 (ko) 피리도[2.1-b]퀴나졸린 유도체의 제조방법
KR820000494B1 (ko) 퀴나졸린 유도체의 제조방법
JPH06199851A (ja) キノリン−3−酢酸誘導体、その製造法と用途